Published on in CHOP News
Translational findings in new models of SURF1 mitochondrial disease also suggest that two drugs, already FDA-approved for other conditions, may prevent neurological decompensation in Leigh syndrome patients.
Published on in CHOP News
Bill & Melinda Gates Foundation grant will help researchers answer important questions about the effects of COVID-19.
Published on in CHOP News
The more we know; the more we can help. Clinical and research leaders from CHOP’s Mitochondrial Medicine team encourage families to join mitoSHARE, a worldwide patient-populated registry initiative stewarded by the United Mitochondrial Disease Foundation (UMDF).
Published on in CHOP News
The model helped identify two supplements that appeared to have therapeutic benefits.
Published on in CHOP News
In a retrospective study, researchers from the Mitochondrial Medicine Frontier Program at Children’s Hospital of Philadelphia (CHOP) and Lund University in Sweden determined the prevalence, severity, and timing of onset for hearing loss across different genetic subtypes of mitochondrial disease.
Published on in CHOP News
Nearly $12 million awarded for four-year study to develop noninvasive methods across four related, multidisciplinary projects.
Published on in CHOP News
Variants of the FBXL4 gene cause a severe form of the disorder with many complications and no approved treatment options.
Published on in CHOP News
New study shows how nicotimamide riboside, part of the vitamin B3 family, could mitigate myopathy caused by a genetic variant.
Published on in CHOP News
While the benefits of exercise may outweigh the risks, genetic status should be considered when recommending it as therapy.
Published on in CHOP News
Breaking Through with Madeline Bell’s “Women Leading the Way” series highlights stories about some of CHOP’s amazing women scientists, and the remarkable breakthroughs they’re making.